Quick Takeaways
- John Peter Gutfreund has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $153,654.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of John Peter Gutfreund
- Location
- New York, NY
- Summary
- The estimated net worth of John Peter Gutfreund is at least $153,654 dollars as of 03 Jul 2023. John Peter Gutfreund is the Former Director of Oncocyte Corp and owns shares of Insight Molecular Diagnostics Inc. (IMDX) stock worth about $153.7K.
- Signature
- /s/ John Peter Gutfreund
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Peter Gutfreund and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Oncocyte Corp ($153,654).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of John Peter Gutfreund
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMDX | Oncocyte Corp | Former Director | $153,654 | 30 Jun 2023 |
Insider Transactions Reported by John Peter Gutfreund:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.